Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Guilloteau, D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 80 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Guilloteau, D; Maziere, B; Moretti, JL; Grognet, JM; de Beco, V
      12th International Symposium of Radiopharmacology - Interlaken (Switzerland) June 12-15, 2001 - Foreword

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    2. Emond, P; Helfenbein, J; Chalon, S; Garreau, L; Vercouillie, J; Frangin, Y; Besnard, JC; Guilloteau, D
      Synthesis of tropane and nortropane analogues with phenyl substitutions asserotonin transporter ligands

      BIOORGANIC & MEDICINAL CHEMISTRY
    3. Vancassel, S; Durand, G; Barthelemy, C; Lejeune, B; Martineau, J; Guilloteau, D; Andres, C; Chalon, S
      Plasma fatty acid levels in autistic children

      PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
    4. Tranquart, F; Saliba, E; Barantin, L; Lanneau, M; Simmer, L; Guilloteau, D; Baulieu, JL
      D2 receptor imaging in neonates using I-123 iodobenzamide brain SPECT

      CLINICAL NUCLEAR MEDICINE
    5. Vercouillie, J; Tarkiainen, S; Halldin, C; Emond, P; Chalon, S; Sandell, J; Langer, O; Guilloteau, D
      Precursor synthesis and radiolabelling of [C-11]ADAM: A potential radioligand for the serotonin transporter exploration by PET

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    6. Bezard, E; Boraud, T; Chalon, S; Brotchie, JM; Guilloteau, D; Gross, CE
      Pallidal border cells: An anatomical and electrophysiological study in the1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey

      NEUROSCIENCE
    7. Bezard, E; Dovero, S; Prunier, C; Ravenscroft, P; Chalon, S; Guilloteau, D; Crossman, AR; Bioulac, B; Brotchie, JM; Gross, CE
      Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease

      JOURNAL OF NEUROSCIENCE
    8. Prunier, C; Tranquart, F; Cottier, JP; Giraudeau, B; Chalon, S; Guilloteau, D; De Toffol, B; Chossat, F; Autret, A; Besnard, JC; Baulieu, JL
      Quantitative analysis of striatal dopamine D2 receptors with I-123-iodolisuride SPECT in degenerative extrapyramidal diseases

      NUCLEAR MEDICINE COMMUNICATIONS
    9. Diot, P; Galinier, E; Grimbert, D; Bugeon, S; Valat, C; Lemarie, E; Diot, E; Baulieu, JL; Besnard, JC; Guilloteau, D
      Characterization of Tc-99m-DTPA aerosols for lung permeability studies

      RESPIRATION
    10. Chalon, S; Vancassel, S; Zimmer, L; Guilloteau, D; Durand, G
      Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission

      LIPIDS
    11. Cantagrel, S; Gressens, P; Bodard, S; Suc, AL; Laugier, J; Guilloteau, D; Chalon, S
      MRNA D-2 dopaminergic receptor expression after hypoxia-ischemia in rat immature brain

      BIOLOGY OF THE NEONATE
    12. Baulieu, JL; Resche, I; Bardies, M; Chauvet, AF; Lecloirec, J; Malhaire, JP; Thomas, E; Faurous, P; Sassolas, G; Pourcelot, L; Chatal, JF; Guilloteau, D; Besnard, JC
      [I-131]-TYR3-octreotide: Clinical dosimetry and use for internal radiotherapy of metastatic paraganglioma and carcinoid tumors

      NUCLEAR MEDICINE AND BIOLOGY
    13. Dolle, F; Bottlaender, M; Demphel, S; Emond, P; Fuseau, C; Coulon, C; Ottaviani, M; Valette, H; Loc'h, C; Halldin, C; Mauclaire, L; Guilloteau, D; Maziere, B; Crouzel, C
      Highly efficient synthesis of [C-11]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    14. Sandell, J; Halldin, C; Helfenbein, J; Chou, YH; Vercouillie, J; Emond, P; Swahn, CG; Guilloteau, D; Farde, L
      Synthesis of [C-11]2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-methyl, -ethyland isopropyl phenyl)nortropane as potential radiotracers for examination of the serotonin transporter with positron emission tomography

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    15. Gouhier, C; Chalon, S; Venier-Julienne, MC; Bodard, S; Benoit, JP; Besnard, JC; Guilloteau, D
      Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide

      NEUROSCIENCE LETTERS
    16. Zimmer, L; Delpal, S; Guilloteau, D; Aioun, J; Durand, G; Chalon, S
      Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex

      NEUROSCIENCE LETTERS
    17. Zimmer, L; Kodas, E; Guilloteau, D; Garreau, L; Besnard, JC; Chalon, S
      Microdialysis as a tool for in vivo study of dopamine transporter functionin rat brains

      JOURNAL OF NEUROSCIENCE METHODS
    18. Zimmer, L; Delion-Vancassel, S; Durand, G; Guilloteau, D; Bodard, S; Besnard, JC; Chalon, S
      Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids

      JOURNAL OF LIPID RESEARCH
    19. Hall, H; Halldin, C; Guilloteau, D; Chalon, S; Emond, P; Besnard, JC; Farde, L; Sedvall, G
      Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [I-125]PE2I

      NEUROIMAGE
    20. Helfenbein, J; Sandell, J; Halldin, C; Chalon, S; Emond, P; Okubo, Y; Chou, YH; Frangin, Y; Douziech, L; Gareau, L; Swahn, CG; Besnard, JC; Farde, L; Guilloteau, D
      PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter

      NUCLEAR MEDICINE AND BIOLOGY
    21. Chalon, S; Emond, P; Bodard, S; Vilar, MP; Thiercelin, C; Besnard, JC; Guilloteau, D
      Time course of changes in striatal dopamine transporters and D-2 receptorswith specific iodinated markers in a rat model of Parkinson's disease

      SYNAPSE
    22. Collet, C; Lecomte, P; Guilloteau, D; Lejeune, B; Lecomte, C; Besnard, JC
      Luteinizing hormone measurement in polycystic ovary syndrome: a practical approach

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    23. Helfenbein, J; Emond, P; Loc'h, C; Bottlaender, M; Ottaviani, M; Guilloteau, D; Maziere, B; Frangin, Y; Chalon, S
      Synthesis of (E)-N-(3-bromoprop-2-enyl)-2 beta-carbomethoxy-3 beta-(4 '-tolyl) nortropane (PE2Br) and radiolabelling of [Br-76]PE2Br: A potential ligand for exploration of the dopamine transporter by PET.

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    24. Helfenbein, J; Emond, P; Sandell, J; Halldin, C; Pereyre, S; Frangin, Y; Garreau, L; Besnard, JC; Guilloteau, D; Chalon, S
      Synthesis and radiolabelling of 2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-isopropylphenyl) nortropane as a radioligand for the exploration of the serotonin transporter by SPET.

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    25. Tranquart, F; Saliba, E; Zimmer, L; Barantin, L; Lanneau, M; Guilloteau, D; Baulieu, JL
      Dopamine D-2 receptor brain imaging in the neonatal period using I-123-IBZM SPECT

      JOURNAL OF NUCLEAR MEDICINE
    26. Baulieu, JL; Ribeiro, MJ; Levilion-Prunier, C; Tranquart, F; Chartier, JR; Guilloteau, D; Cottier, JP; Besnard, JC; Pourcelot, L; Autret, A
      Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using I-123-iodolisuride SPET

      NUCLEAR MEDICINE COMMUNICATIONS
    27. Zimmer, L; Durand, G; Guilloteau, D; Chalon, S
      n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex

      LIPIDS
    28. Helfenbein, J; Loc'h, C; Bottlaender, M; Emond, P; Coulon, C; Ottaviani, M; Fuseau, C; Chalon, S; Guenther, I; Besnard, JC; Frangin, Y; Guilloteau, D; Maziere, B
      A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: Pharmacological evaluation and PET experiments

      LIFE SCIENCES
    29. Chalon, S; Garreau, L; Emond, P; Zimmer, L; Vilar, MP; Besnard, JC; Guilloteau, D
      Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2 beta-carboxymethoxy-3 beta-(4 '-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    30. GUILLOTEAU D; EMOND P; BAULIEU JL; GARREAU L; FRANGIN Y; POURCELOT L; MAUCLAIRE L; BESNARD JC; CHALON S
      EXPLORATION OF THE DOPAMINE TRANSPORTER - IN-VITRO AND IN-VIVO CHARACTERIZATION OF A HIGH-AFFINITY AND HIGH-SPECIFICITY IODINATED TROPANE DERIVATIVE TA-CARBOMETHOXY-3-BETA-(4'-METHYLPHENYL)NORTROPANE (PE2I)

      Nuclear medicine and biology
    31. EMOND P; FARDE L; CHALON S; BELZUNG C; MAUCLAIRE V; CHIRON JP; HALLDIN C; BESNARD JC; GUILLOTEAU D
      TOXICITY, MUTAGENICITY, AND BEHAVIORAL-EFFECTS OF BETA-CIT, A LIGAND FOR DOPAMINE TRANSPORTER EXPLORATION BY SPECT

      Nuclear medicine and biology
    32. CHALON S; EMOND P; BESNARD JC; GUILLOTEAU D
      TIME-COURSE OF CHANGES IN THE DOPAMINE TRANSPORTERS AND D-2 RECEPTORSIN A RAT MODEL OF PARKINSONS-DISEASE

      European journal of neuroscience
    33. KUIKKA JT; BAULIEU JL; HILTUNEN J; HALLDIN C; BERGSTROM KA; FARDE L; EMOND P; CHALON S; YU MX; NIKULA T; LAITINEN T; KARHU J; TUPALA E; HALLIKAINEN T; KOLEHMAINEN V; MAUCLAIRE L; MAZIERE B; TIIHONEN J; GUILLOTEAU D
      PHARMACOKINETICS AND DOSIMETRY OF I-123 LABELED PE2I IN HUMANS, A RADIOLIGAND FOR DOPAMINE TRANSPORTER IMAGING

      European journal of nuclear medicine
    34. ZIMMER L; HEMBERT S; DURAND G; BRETON P; GUILLOTEAU D; BESNARD JC; CHALON S
      CHRONIC N-3 POLYUNSATURATED FATTY-ACID DIET-DEFICIENCY ACTS ON DOPAMINE METABOLISM IN THE RAT FRONTAL-CORTEX - A MICRODIALYSIS STUDY

      Neuroscience letters
    35. HUGUET F; GUERRAOUI A; BARRIER L; GUILLOTEAU D; TALLINEAU C; CHALON S
      CHANGES IN EXCITATORY AMINO-ACID LEVELS AND TISSUE ENERGY METABOLITESOF NEONATE RAT-BRAIN AFTER HYPOXIA AND HYPOXIA-ISCHEMIA

      Neuroscience letters
    36. ZIMMER L; EMOND P; FRANGIN Y; CHALON S; BESNARD JC; GUILLOTEAU D
      SPECIFICITY OF PE2I, ANEW COCAINE DERIVATE FOR DOPAMINE TRANSPORTER IMAGING - AN IN-VIVO STUDY BY DUAL-PROBE MICRODIALYSIS

      The Journal of nuclear medicine
    37. HALLDIN C; GUILLOTEAU D; OKUBO Y; LUNDKVIST C; OLSSON H; KARLSSON P; CHALON S; EMOND P; SWAHN CG; FARDE L
      PET-CHARACTERIZATION OF [C-11] PE2I BINDING TO DOPAMINE TRANSPORTER IN THE MONKEY BRAIN

      The Journal of nuclear medicine
    38. SANDELL J; HELFENBEIN J; HALLDIN C; OKUBO Y; CHALON S; FRANGIN Y; GALINIER E; SWAHN CG; GUILLOTEAU D; FARDE L
      PRECURSOR SYNTHESIS, RADIOLABELING AND PET EXAMINATION IN MONKEY OF 3POTENT SEROTONIN TRANSPORTER RADIOLIGANDS

      The Journal of nuclear medicine
    39. HELFENBEIN J; BOTTLAENDER M; COULON C; EDMOND P; OTTAVIANI M; FUSEAU C; CHALON S; LOCH C; FRANGIN Y; GUILLOTEAU D; MAZIERE B
      PHARMACOLOGICAL EVALUATION AND PET STUDIES OF BR-76-PE2BR, A HIGHLY SELECTIVE RADIOBROMINATED COCAINE ANALOG FOR QUANTITATION OF DOPAMINE UPTAKE SITES

      The Journal of nuclear medicine
    40. Chalon, S; Delion-Vancassel, S; Belzung, C; Guilloteau, D; Leguisquet, AM; Besnard, JC; Durand, G
      Dietary fish oil affects monoaminergic neurotransmission and behavior in rats

      JOURNAL OF NUTRITION
    41. EMOND P; CHALON S; GARREAU L; DOGNON AM; BODARD S; FRANGIN Y; BAULIEU JL; BESNARD JC; GUILLOTEAU D
      A NEW IODINATED TROPANE DERIVATIVE (BETA-CDIT) FOR IN-VIVO DOPAMINE TRANSPORTER EXPLORATION - COMPARISON WITH BETA-CIT

      Synapse
    42. EMOND P; BOAZI M; DUCHENE A; CHALON S; BESNARD JC; GUILLOTEAU D; FRANGIN Y
      SYNTHESIS OF IODINATED AND RADIOIODINATED -2-BETA-CARBOMETHOXY-3-BETA-(3',4'-DICHLOROPHENYL) NORTROPANE (BETA-CDIT) - A LIGAND FOR THE DOPAMINE TRANSPORTER

      Journal of labelled compounds & radiopharmaceuticals
    43. RAHALPEROLA V; REVIERS MTH; CHALON S; BODARD S; GUILLOTEAU D; HAMAMAH S; LANSAC J; ROYERE D
      DOES NEONATAL HYPOXIA-ISCHEMIA INFLUENCE MALE REPRODUCTIVE DEVELOPMENT AND FUNCTION

      Human reproduction
    44. CHALON S; EMOND P; THIERCELIN C; BODARD S; GARREAU L; FRANGIN Y; MAUCLAIRE L; BESNARD JC; GUILLOTEAU D
      ROP-2E-ENYL)-2-BETA-CARBOMETHOXY-3-BETA-(4'-METHYL PHENYL) NORTROPANEAS A SELECTIVE MARKER FOR THE DOPAMINE TRANSPORTER - VALIDATION IN A RAT MODEL OF PARKINSONS-DISEASE

      The Journal of nuclear medicine
    45. DIOT P; GALINIER E; GRIMBERT D; BUJON S; FONTAINE V; BESNARD JC; BAULIEU JL; GUILLOTEAU D
      ALVEOLO-CAPILLAR PERMEABILITY AND VENTILATION STUDIES - ARE TC-99M-DTPA AEROSOLS REALLY VALID

      The Journal of nuclear medicine
    46. GUILLOTEAU D; CHALON S; BLAUENSTEIN P; BAULIEU JL; BESNARD JC; SCHUBIGER PA
      MONOAMINE-OXIDASE-B EXPLORATION BY SPET - WHY AND HOW

      The Journal of nuclear medicine
    47. GARREAU L; EMOND P; BELZUNG C; GUILLOTEAU D; FRANGIN Y; BESNARD JC; CHALON S
      RBOMETHOXY-3-BETA-(3',4'-DICHLOROPHENYL)NORTROPANE (BETA-CDIT), A TROPANE DERIVATIVE - PHARMACOLOGICAL CHARACTERIZATION AS A SPECIFIC LIGAND FOR THE DOPAMINE TRANSPORTER IN THE RODENT BRAIN

      The Journal of pharmacology and experimental therapeutics
    48. EMOND P; GARREAU L; CHALON S; BOAZI M; CAILLET M; BRICARD J; FRANGIN Y; MAUCLAIRE L; BESNARD JC; GUILLOTEAU D
      SYNTHESIS AND LIGAND-BINDING OF NORTROPANE DERIVATIVES - N-SUBSTITUTED BETA-CARBOMETHOXY-3-BETA-(4'-IODOPHENYL)NORTROPANE AND L)-2-BETA-CARBOMETHOXY-3-BETA-(3',4'-DISUBSTITUTED PHENYL)NORTROPANE - NEW HIGH-AFFINITY AND SELECTIVE COMPOUNDS FOR THE DOPAMINE TRANSPORTER

      Journal of medicinal chemistry
    49. DELION S; CHALON S; GUILLOTEAU D; LEJEUNE B; BESNARD JC; DURAND G
      AGE-RELATED-CHANGES IN PHOSPHOLIPID FATTY-ACID COMPOSITION AND MONOAMINERGIC NEUROTRANSMISSION IN THE HIPPOCAMPUS OF RATS FED A BALANCED ORAN N-3 POLYUNSATURATED FATTY ACID-DEFICIENT DIET

      Journal of lipid research
    50. BAULIEU JL; VAILLANT L; BAULIEU F; GUILLOTEAU D; MACHET L; LORETTE G
      MELANOMA SCINTIGRAPHY WITH BENZAMIDE DERIVATIVES

      Journal of investigative dermatology
    51. PELLEVOISIN C; CHALON S; KUNG HF; BESNARD JC; GUILLOTEAU D
      IS TISCH A SUITABLE TRACER FOR IN-VIVO STUDY OF MODIFICATIONS OF THE DOPAMINE D-1 RECEPTOR

      Nuclear medicine and biology
    52. CHALON S; PELLEVOISIN C; BODARD S; VILAR MP; BESNARD JC; GUILLOTEAU D
      IODINATED PK-11195 AS AN EX-VIVO MARKER OF NEURONAL INJURY IN THE LESIONED RAT-BRAIN

      Synapse
    53. PELLEVOISIN C; GUILLOTEAU D; BAULIEU JL; LOCH C; DOGNON AM; MAUCLAIRE L; SACCAVINI JC; BESNARD JC; CHALON S
      IODALISURIDE AND IODOBENZAMIDE, 2 LIGANDS FOR SPECT EXPLORATION OF THE DOPAMINERGIC D2 RECEPTORS - A COMPARATIVE-STUDY

      Synapse
    54. HUGUET F; FAGRET D; CAILLET M; PIRIOU A; BESNARD JC; GUILLOTEAU D
      INTERACTION OF METAIODOBENZYLGUANIDINE WITH CARDIOACTIVE DRUGS - AN IN-VITRO STUDY

      European journal of nuclear medicine
    55. EMOND P; GARREAU L; CHALON S; BOAZI M; FRANGIN Y; BESNARD JC; GUILLOTEAU D
      THE BETA-CDIT, A NEW COCAINE CONGENER FOR DOPAMINE TRANSPORTER EXPLORATION WITH HIGH SPECIFICITY AND VALUABLE IN-VIVO KINETIC

      The Journal of nuclear medicine
    56. ZOUAKIA A; GUILLOTEAU D; ZIMMER L; BESNARD JC; CHALON S
      EVOLUTION OF DOPAMINE-RECEPTORS IN THE RAT AFTER NEONATAL HYPOXIA-ISCHEMIA - AUTORADIOGRAPHIC STUDIES

      Life sciences
    57. RAFII H; CHALON S; OMBETTA JE; FRANGIN Y; POURCELOT L; BESNARD JC; BODARD S; GUILLOTEAU D
      AN IODINATED DERIVATIVE OF MOCLOBEMIDE AS POTENTIAL RADIOLIGAND FOR BRAIN MAO-A EXPLORATION

      Life sciences
    58. DELION S; CHALON S; GUILLOTEAU D; BESNARD JC; DURAND G
      ALPHA-LINOLENIC ACID DIETARY DEFICIENCY ALTERS AGE-RELATED-CHANGES OFDOPAMINERGIC AND SEROTONINERGIC NEUROTRANSMISSION IN THE RAT FRONTAL-CORTEX

      Journal of neurochemistry
    59. LENA I; OMBETTA JE; CHALON S; DOGNON AM; BAULIEU JL; FRANGIN Y; GARREAU L; BESNARD JC; GUILLOTEAU D
      IODODERIVATIVE OF PARGYLINE - A POTENTIAL TRACER FOR THE EXPLORATION OF MONOAMINE-OXIDASE SITES BY SPECT

      Nuclear medicine and biology
    60. RAFII H; CHALON S; OMBETTA JE; FRANGIN Y; GARREAU L; DOGNON AM; LENA I; BODARD S; VILAR MP; BESNARD JC; GUILLOTEAU D
      SYNTHESIS AND CHARACTERIZATION OF [I-125] N-(2-AMINOETHYL)-4-IODOBENZAMIDE SELECTIVE AS A MONOAMINE-OXIDASE-B INHIBITOR

      Nuclear medicine and biology
    61. BRANGER C; GARREAU L; DOGNON AM; FRANGIN Y; CAILLET M; OMBETTAGOKA JE; CHALON S; BESNARD JC; GUILLOTEAU D
      SYNTHESIS OF 4'-IODO-5-METHOXY-VALEROPHENONE O-(2-AMINOETHYL)OXIME ASAN AGENT FOR EXPLORATION OF SEROTONINERGIC TRANSPORTER

      Nuclear medicine and biology
    62. BRANGER C; GARREAU L; FRANGIN Y; CHALON S; DUBOIS P; DOGNON AM; OMBETTAGOKA JE; BESNARD JC; GUILLOTEAU D
      RADIOIODINATED ANALOGS OF XYLAMINE - N-(2-CHLOROETHYL)-N-ETHYL-2-[I-125]IODOBENZYLAMINE AND N,N-DIETHYL-2-[I-125]IODOBENZYLAMINE AS POTENTIAL TOOLS FOR MONOAMINE UPTAKE EXPLORATION BY SPECT

      Journal of labelled compounds & radiopharmaceuticals
    63. FIGNON A; GUILLOTEAU D; LANSAC J; BESNARD JC
      HOOK EFFECT IN IMMUNORADIOMETRIC ASSAY FOR HUMAN CHORIONIC GONADOTROPINE AS A MARKER FOR TROPHOBLASTIC DISEASE

      European journal of obstetrics, gynecology, and reproductive biology
    64. CHALON S; ZOUAKIA A; SALIBA E; ZIMMER L; BESNARD JC; GUILLOTEAU D
      EVOLUTION OF STRIATAL DOPAMINE-RECEPTORS AFTER A NEONATAL HYPOXIC-ISCHEMIC INJURY IN THE RAT

      Pediatric research
    65. VERDOT L; BERTIN B; GUILLOTEAU D; STROSBERG AD; HOEBEKE J
      CHARACTERIZATION OF PHARMACOLOGICALLY ACTIVE ANTIPEPTIDE ANTIBODIES DIRECTED AGAINST THE FIRST AND 2ND EXTRACELLULAR LOOPS OF THE SEROTONIN5-HT1A RECEPTOR

      Journal of neurochemistry
    66. TESSIER L; PATAT F; SCHMITT N; LETHIECQ M; FRANGIN Y; GUILLOTEAU D
      SIGNIFICANCE OF MASS AND VISCOUS LOADS DISCRIMINATION FOR AN AT-QUARTZ BLOOD-GROUP IMMUNOSENSOR

      Sensors and actuators. B, Chemical
    67. TRANQUART F; LEBRAS FH; DETOFFOL B; AUTRET A; GUILLOTEAU D; BAULIEU JL
      PROGRESSIVE SUPRANUCLEAR PALSY - DOPAMINE D2 RECEPTOR TOMOSCINTIGRAPHY TO DETECT L-DOPAMINE EFFICIENCY

      La Presse medicale
    68. GALINIER E; OMBETTA JE; FRANGIN Y; MERTENS J; BESNARD JC; GUILLOTEAU D
      RADIOLABELING OPTIMIZATION OF )-2,3-DIHYDRO-5-HYDROXY-5H-IMIDAZO[2,1-A]ISOINDOLE OR [I-125] IODO MAZINDOL - A POTENTIAL TOOL FOR SPECT EXPLORATIONS

      Journal of labelled compounds & radiopharmaceuticals
    69. ZOUAKIA A; CHALON S; KUNG HF; DOGNON AM; SALIBA E; BESNARD JC; GUILLOTEAU D
      RADIOIODINATED TRACERS FOR THE EVALUATION OF DOPAMINE-RECEPTORS IN THE NEONATAL RAT-BRAIN AFTER HYPOXIC-ISCHEMIC INJURY

      European journal of nuclear medicine
    70. GARREAU L; OMBETTA JE; GALINIER E; DOGNON AM; CHALON S; FRANGIN Y; BESNARD JC; GUILLOTEAU D
      NEW RADIOLIGANDS FOR THE EXPLORATION OF DOPAMINE UPTAKE SITES BY SPET- DEVELOPMENT OF DERIVATIVES OF MAZINDOL - STRUCTURE AFFINITY RELATIONSHIP

      The Journal of nuclear medicine
    71. GUILLOTEAU D; PELLEVOISIN C; CHALON S; MAZIERE B; SACCAVINI JC; BESNARD JC
      COMPARISON OF 3 SPECIFIC D2 DOPAMINE-RECEPTOR RADIOIODINATED LIGANDS IN ANIMAL-MODELS OF QUANTITATIVE RECEPTOR ALTERATIONS

      The Journal of nuclear medicine
    72. DELION S; CHALON S; HERAULT J; GUILLOTEAU D; BESNARD JC; DURAND G
      CHRONIC DIETARY ALPHA-LINOLENIC ACID DEFICIENCY ALTERS DOPAMINERGIC AND SEROTONINERGIC NEUROTRANSMISSION IN RATS

      The Journal of nutrition
    73. REVOL A; BADONNEL Y; CARREAU S; CASTANIER M; COLLET C; DELVIGNE L; DENIS I; GUILLOTEAU D; MOATTI JP; PATRICOT MC; ROGER M
      MEASUREMENT OF SERUM HLH BY IMMUNOASSAY A ND BIOASSAY - RESULTS OF A MULTICENTER STUDY

      Annales de biologie clinique
    74. GALINIER E; GARREAU L; DOGNON AM; OMBETTAGOKA JE; FRANGIN Y; CHALON S; BESNARD JC; GUILLOTEAU D
      SYNTHESIS OF HALOGENATED ANALOGS OF -2,3-DIHYDRO-5-HYDROXY-5H-IMIDAZO[2,1-A]-ISOINDOLE OR MAZINDOL FOR EXPLORATION OF THE DOPAMINE TRANSPORTER

      European journal of medicinal chemistry
    75. GUILLOTEAU D; LENA I; OMBETTA JE; GARREAU L; BESNARD JC
      SYNTHESIS AND CHARACTERIZATION OF A IODOPARGYLINE-A POTENTIAL LIGAND FOR SPECT STUDY OF BRAIN MONOAMINE-OXIDASE

      The Journal of nuclear medicine
    76. RODIER N; AGAFONOV V; CENSE JM; GALINIER E; OMBETTA JE; FRANGIN Y; GUILLOTEAU D
      5-(3-IODOPHENYL)-2,3-DIHYDRO-5-HYDROXY-5H -IMIDAZO[2,1-A]ISOINDOLE

      Acta crystallographica. Section C, Crystal structure communications
    77. PELLEVOISIN C; CHALON S; ZOUAKIA A; DOGNON AM; FRANGIN Y; BAULIEU JL; BESNARD JC; GUILLOTEAU D
      COMPARISON OF 2 RADIOIODINATED LIGANDS OF DOPAMINE-D2 RECEPTORS IN ANIMAL-MODELS - IODOBENZAMIDE AND IODOETHYLSPIPERONE

      Life sciences
    78. PELLEVOISIN C; CHALON S; GUILLOTEAU D; BESNARD JC
      DIFFERENTIAL CHANGES IN STRIATAL D1 AND D2 DOPAMINE-RECEPTORS AFTER EXCITOTOXIN-INDUCED LESIONS IN RATS

      Journal of neurochemistry
    79. FOULON C; GUILLOTEAU D; BAULIEU JL; RIBEIROBARRAS MJ; DESPLANCHES G; FRANGIN Y; BESNARD JC
      ESTROGEN-RECEPTOR IMAGING WITH 17-ALPHA-[I-123]IODOVINYL-11-BETA-METHOXYESTRADIOL (MIVE2) .1. RADIOTRACER PREPARATION AND CHARACTERIZATION

      International journal of radiation applicatons and instrumentation. Part B: Nuclear medicine and biology
    80. RIBEIROBARRAS MJ; FOULON C; BAULIEU JL; GUILLOTEAU D; BOUGNOUX P; LANSAC J; BESNARD JC
      ESTROGEN-RECEPTOR IMAGING WITH 17-ALPHA-[I-123]IODOVINYL-11-BETA-METHOXYESTRADIOL (MIVE2) .2. PRELIMINARY-RESULTS IN PATIENTS WITH BREAST-CARCINOMA

      International journal of radiation applicatons and instrumentation. Part B: Nuclear medicine and biology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 15:26:47